Electromed, Inc.

ELMD

Electromed, Inc.

ELMD

Insider Sentiment (TTM):

Last Purchase:2024-03-01Last Sale:2026-06-08Shares Purchased (TTM):0Shares Sold (TTM):64,654

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:4,012,204Shares Outstanding:8,211,220Institutional Ownership Pct.:48.86%

Earnings Market Reaction:

Filing Date:2026-05-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	17	14	14	15	15	16	14	16	12	10	7	7
Accounts Receivable Net Current	28	26	25	25	23	23	22	23	24	23	23	24
Contract With Customer Asset Net Current	1	1	1	1	1	1	1	1	1	1	1	0
Inventory Net	3	3	4	3	3	3	3	4	4	5	4	4
Income Taxes Receivable	0	0	0	0	1	1	-	0	-	-	-	-
Prepaid Expense And Other Assets Current	1	1	1	0	0	1	1	0	1	1	1	2
Assets Designated To Closed Block Income Tax Recei…	-	-	-	-	-	-	-	-	0	-	-	-
Assets Current	50	46	45	45	44	44	41	44	41	39	36	38
Property Plant And Equipment Net	5	5	5	5	5	5	5	5	5	5	6	6
Finite Lived Intangible Assets Net	0	0	0	0	1	1	1	1	1	1	1	1
Other Assets Noncurrent	1	1	1	1	1	0	0	0	0	0	0	0
Deferred Income Tax Assets Net	2	2	2	2	2	2	2	2	2	2	2	2
Assets	59	55	54	54	52	52	49	52	49	47	44	46
Liabilities Current
Liabilities And Stockhold…
Accounts Payable Current	3	2	3	3	2	2	2	1	1	1	1	1
Employee Related Liabilities Current	5	4	3	5	4	4	2	4	3	3	2	3
Accrued Income Taxes Current	-	0	-	0	0	-	0	0	-	0	0	0
Product Warranty Accrual Classified Current	2	2	2	2	2	2	2	2	2	1	1	1
Other Accrued Liabilities Current	1	1	1	1	1	2	2	1	1	1	1	2
Liabilities Current	10	9	9	10	9	9	7	8	6	7	6	8
Liabilities Other Than Longterm Debt Noncurrent	-	-	-	-	-	0	0	0	0	0	0	0
Other Liabilities Noncurrent	0	0	0	0	0	-	-	0	-	-	-	-
Liabilities	10	9	9	11	9	9	7	8	6	7	6	8
Stockholders Equity
Stockholders Equity Inclu…
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	24	23	22	22	21	21	21	21	20	20	19	19
Retained Earnings Accumulated Deficit	25	22	22	21	23	23	21	24	22	21	19	19
Stockholders Equity	49	45	45	43	44	44	41	45	43	40	38	38
Liabilities And Stockholders Equity	59	55	54	54	52	52	49	52	49	47	44	46
Allowance For Doubtful Accounts Receivable Current	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	13	13	13	13	13	13	13	13	13	13	13	13
Common Stock Shares Issued	8	8	8	8	9	9	8	9	9	9	9	9
Shares Outstanding	8	8	8	8	9	9	8	9	9	9	9	9

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	9.57%	7.92%	17.69%	-14.90%	-17.00%	-8.77%	38.57%	67.02%	49.74%	-	-	-
2025	8.59%	16.07%	30.11%	-12.91%	-23.32%	-20.48%	-8.23%	-8.98%	-20.59%	19.89%	17.57%	22.31%
2024	8.98%	13.88%	8.35%	69.53%	51.58%	82.45%	-16.50%	-14.16%	-12.74%	26.42%	43.80%	79.50%
2023	-	-	-	-	-	-	-	-	-	8.84%	7.72%	4.17%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	4.91	4.86	5.09	4.31	5.19	5.10	5.53	5.75	6.53	5.97	6.27	4.69
Quick Ratio	4.53	4.39	4.59	3.95	4.79	4.68	4.99	5.23	5.78	5.17	5.37	3.97
Working Capital	40.00M	36.19M	35.80M	34.61M	35.68M	35.52M	33.59M	36.50M	35.00M	32.69M	30.42M	29.73M
Leverage & Debt
Debt to Equity	0.21	0.21	0.20	0.25	0.19	0.20	0.18	0.17	0.15	0.16	0.15	0.22
Interest Coverage TTM	27.40	22.06	18.46	15.48	10.87	10.79	11.23	10.48	17.19	21.23	27.19	51.38
Debt Ratio	0.17	0.17	0.17	0.20	0.16	0.17	0.15	0.15	0.13	0.14	0.13	0.18
Efficiency & Turnover
Asset Turnover TTM	1.28	1.28	1.29	1.21	1.21	1.20	1.23	1.12	1.17	1.17	1.18	1.10
Days Sales Outstanding TTM	131.48	129.96	129.87	136.86	140.65	140.07	146.55	158.31	157.79	157.26	162.97	171.55
Receivables Turnover TTM	2.78	2.81	2.81	2.67	2.60	2.61	2.49	2.31	2.31	2.32	2.24	2.13
Per Share Metrics
Diluted EPS TTM	1.17	1.03	0.94	0.85	0.80	0.76	0.72	0.58	0.49	0.45	0.37	0.36
Free Cash Flow Per Share TTM	1.14	0.96	1.02	1.28	1.36	1.30	1.33	1.03	0.57	0.44	0.15	-0.04
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	78.44%	78.23%	78.04%	78.08%	77.55%	76.81%	76.62%	76.26%	76.41%	76.51%	75.78%	75.98%
Operating Profit Margin TTM	18.25%	16.66%	15.69%	15.09%	14.58%	14.52%	14.68%	12.03%	10.73%	9.86%	8.26%	8.34%
Net Profit Margin TTM	14.08%	13.06%	12.38%	11.78%	11.66%	11.34%	11.34%	9.41%	8.14%	7.62%	6.51%	6.59%
Growth Metrics
Net Revenue Growth (1Y)	16.79%	15.49%	16.05%	16.97%	14.85%	15.35%	14.73%	13.83%	17.00%	18.03%	17.53%	15.38%
Net Income Growth (1Y)	41.10%	32.96%	26.74%	46.35%	64.43%	71.78%	99.66%	62.67%	73.09%	88.73%	66.41%	37.35%
EPS Growth (1Y)	45.97%	35.43%	30.42%	48.22%	65.80%	74.24%	99.03%	60.79%	70.99%	86.48%	64.63%	37.48%
Valuation Metrics
P/E TTM	19.02	26.78	24.92	24.67	28.30	36.81	28.42	24.99	31.76	23.68	27.38	28.63
P/B TTM	3.91	5.30	4.57	4.30	4.61	5.71	4.43	2.89	3.25	2.31	2.32	2.41
P/S TTM	2.68	3.50	3.09	2.90	3.30	4.18	3.22	2.35	2.59	1.80	1.78	1.89
Market Cap	192.22M	240.84M	204.32M	185.91M	202.69M	248.94M	183.88M	128.69M	138.34M	93.23M	88.70M	90.65M
Enterprise Value	175.24M	227.05M	190.21M	170.62M	187.45M	232.71M	170.02M	112.61M	126.62M	82.79M	81.68M	83.27M
Calculated Values
Free Cash Flow TTM	9.35M	7.94M	8.47M	10.83M	11.58M	10.92M	11.41M	8.78M	4.89M	3.73M	1.25M	-333.00K
Net Debt	-16.99M	-13.79M	-14.11M	-15.29M	-15.24M	-16.24M	-13.86M	-16.08M	-11.71M	-10.43M	-7.02M	-7.37M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-08Sale

Owner: Cunniff, James L.

Title: CEO and President

Shares: 9,700

Price/Share: $36.94

Value: $358,318.00

Shares Owned: 147,751

Relationship: Director,Officer

Ownership: Direct

2026-06-04Sale

Owner: Nagel, Bradley M.

Title: Chief Financial Officer

Shares: 11,801

Price/Share: $36.72

Value: $433,332.72

Shares Owned: 19,638

Relationship: Officer

Ownership: Direct

2026-05-15Sale

Owner: Skarvan, Kathleen

Title: -

Shares: 40,000

Price/Share: $35.80

Value: $1,432,000.00

Shares Owned: 35,622

Relationship: Director

Ownership: Direct

2025-09-11Sale

Owner: Summers, Andrew

Title: -

Shares: 3,153

Price/Share: $24.42

Value: $76,996.26

Shares Owned: -

Relationship: Director

Ownership: Indirect

2025-02-24Sale

Owner: Summers, Andrew

Title: -

Shares: 50,751

Price/Share: $27.30

Value: $1,385,502.30

Shares Owned: 65,714

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-08	Cunniff, James L.	Director,Officer	CEO and President	Direct	Sale	9,700	36.94	$358,318.00	147,751	4
2026-06-04	Nagel, Bradley M.	Officer	Chief Financial Officer	Direct	Sale	11,801	36.72	$433,332.72	19,638	4
2026-05-15	Skarvan, Kathleen	Director	-	Direct	Sale	40,000	35.80	$1,432,000.00	35,622	4
2025-09-11	Summers, Andrew	Director	-	Indirect	Sale	3,153	24.42	$76,996.26	0	4
2025-02-24	Summers, Andrew	Director	-	Indirect	Sale	50,751	27.30	$1,385,502.30	65,714	4
2025-02-18	Skarvan, Kathleen	Director	-	Direct	Sale	38,954	29.28	$1,140,573.12	32,622	4
2024-12-05	Summers, Andrew	Director	-	Indirect	Sale	37,404	28.78	$1,076,487.12	146,827	4
2024-12-04	Summers, Andrew	Director	-	Indirect	Sale	12,731	29.98	$381,675.38	165,755	4
2024-11-19	Skarvan, Kathleen	Director	-	Direct	Sale	50,602	27.92	$1,412,807.84	52,394	4
2024-03-01	Cunniff, James L.	Director,Officer	CEO and President	Direct	Purchase	9,000	15.25	$137,250.00	10,000	4
2023-12-14	Summers, Andrew	Director	-	Indirect	Purchase	28,797	10.50	$302,368.50	351,921	4
2023-11-21	Cunniff, James L.	Director,Officer	CEO and President	Direct	Purchase	1,000	10.56	$10,560.00	1,000	4
2023-07-12	Skarvan, Kathleen	Director	-	Direct	Sale	1,107	10.83	$11,988.81	142,449	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

48.86%

Inst. Shares: 4,012,204

Shares Outstanding: 8,211,220

2025-12-31

49.98%

Inst. Shares: 4,133,281

Shares Outstanding: 8,270,565

2025-09-30

43.07%

Inst. Shares: 3,584,207

Shares Outstanding: 8,322,782

2025-06-30

39.73%

Inst. Shares: 3,358,634

Shares Outstanding: 8,454,100

2025-03-31

37.88%

Inst. Shares: 3,218,232

Shares Outstanding: 8,495,005

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	4,012,204	8,211,220	48.86%
2025-12-31	4,133,281	8,270,565	49.98%
2025-09-30	3,584,207	8,322,782	43.07%
2025-06-30	3,358,634	8,454,100	39.73%
2025-03-31	3,218,232	8,495,005	37.88%
2024-12-31	2,774,184	8,424,534	32.93%
2024-09-30	2,133,880	8,564,489	24.92%
2024-06-30	1,972,090	8,562,245	23.03%
2024-03-31	1,873,839	8,565,725	21.88%
2023-12-31	1,367,845	8,545,120	16.01%
2023-09-30	1,820,069	8,537,388	21.32%
2023-06-30	1,882,792	8,463,684	22.25%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Electromed, Inc. (ELMD) — SEC Financial Statements & Analysis

Electromed, Inc. (ELMD) is a electromedical & electrotherapeutic apparatus company, incorporated in MN. Electromed, Inc. trades on NYSE as: ELMD. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Electromed, Inc. reported a 16.79% year-over-year revenue growth, a Gross Profit Margin of 78.44% (TTM), a Debt-to-Equity ratio of 0.21x, a Price-to-Sales (P/S) ratio of 2.68x (TTM), a Price-to-Book (P/B) ratio of 3.91x (TTM), at a market cap of $192.22M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 16.79%
Gross Profit Margin TTM: 78.44%
Debt To Equity: 0.21x
P/S TTM: 2.68x
P/B TTM: 3.91x
Market Cap: $192.22M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Electromed, Inc. in?

Electromed, Inc. (ELMD) operates in the Electromedical & Electrotherapeutic Apparatus industry.

What is ELMD's market cap?

Electromed, Inc. (ELMD) has a market capitalization of $192.22M as of 2026-03-31.

What is ELMD's P/E ratio?

Electromed, Inc. (ELMD)'s trailing twelve month P/E ratio is 19.02x as of 2026-03-31.

What exchange does ELMD trade on?

Electromed, Inc. (ELMD) trades on the NYSE.

Where is Electromed, Inc. incorporated?

Electromed, Inc. is incorporated in MN.

Electromed, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Electromed, Inc. (ELMD) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Electromedical & Electrotherapeutic Apparatus

Wall Street's data.
Main Street's price.

Electromed, Inc. (ELMD) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Electromedical & Electrotherapeutic Apparatus

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.